Company profile
Shattuck Labs, Inc.
NASDAQ: STTK · Healthcare · Biotechnology
#877 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
50DFH 46DQ 62GM 35SS 51
v0.1 · 65/100 weight · provisional
↑ Altman-Z, balance-sheet leverage · ↓ revenue growth (YoY), operating margin
Methodology →Revenue TTM
$1.0M
Rev growth YoY (TTM)
-78.3%
Net income (FY)
-$48.8M
Employees
40
as of 2026-08-12
Market cap
$648.9M
as of 2026-08-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.0M$1.0M2025
Net income-$48.8M-$48.8M2025
Operating income-$51.5M-$51.5M2025
Total assets$91.0M$91.0M2025
Liabilities$8.6M$8.6M2025
Equity$82.4M$82.4M2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
License100%
By geography
Not disclosed.
The read
What is Shattuck Labs, Inc.’s revenue?
Shattuck Labs, Inc. booked $1.0M in FY2025 revenue, contracting 83% year over year — slower than 89% of Healthcare companies we track, at a -4880.9% net margin.
Peers · Healthcare
Sintx Technologies, Inc.35DEhouse Global, Inc.——60 Degrees Pharmaceuticals, Inc.34DRavenQuest BioMed Inc.——The CannaBusiness Group, Inc.——INDVR Brands Inc.——Neighbors
Travis →Key facts
CEOTaylor H. Schreiber
SectorHealthcare
IndustryBiotechnology
HeadquartersAustin, TX
ExchangeNASDAQ: STTK
Employees40
IPO date2020-10-09
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.